Oxford Global Conferences are proud to announce the new Inhalation & Respiratory Drug Delivery Congress, taking place on 18 – 19 May 2016 at the Kensington Close Hotel in London, UK. The congress is an exclusive opportunity for over 150 drug delivery and formulation experts to exchange their experiences, engage in scientific discussions and debate success stories and solutions to improve the inhalation and respiratory drug delivery industry performance. Furthermore it will be co-located with the 2nd Annual Formulation & Drug Delivery Congress 2016.
The inhalation and respiratory drug delivery market represents a continuously growing area of the global drug delivery industry. The rapid growth of the market is attributed to the unquestionable potential of inhaled therapies, developments of analytical tools for inhaled medicines and the advancements of inhalation device technologies that have made inhalation drug delivery easier and patient-friendly. A recent survey has also forecasted that the global market for inhalation drug delivery technologies will reach $43.9 billion by 2018.
- Joy Conway – Respiratory Sciences and Lung Imaging, Southampton University
- Peter Daley-Yates – Clinical Pharmacology, GlaxoSmithKline
- Ben Forbes – Pharmaceutics , King’s College London
- Per Gerde – Inhalation Toxicology, Karolinska Institutet
- Yuji Kasuya – Daiichi Sankyo
- Holger Memmesheimer – Respiratory Drug Delivery, Boehringer Ingelheim
- Beverley Patterson – Actavis
- Robert Price – Pharmaceutics, University of Bath
- Jonathan Reid – Physical Chemistry, University of Bristol
- John S. Patton – Dance Pharmaceuticals
- Louise Sheridan – AstraZeneca
- Janis Shute – Pharmacology, University of Portsmouth
- Jan Olof Svensson – Inhalation, AstraZeneca
- Frank Thielmann – Inhalation New Solids, Novartis
- Mike Tobyn – Bristol-Myers Squibb
- Thys van der Molen – Primary Care Respiratory Medicine, University of Groningen
- Claudia Vincenzi – Respiratory Regulatory CMC, Mylan Pharma
- Andy West – Ex vivo Bioimaging UK, GlaxoSmithKline
On day one our highly distinguished speakers will focus on the key developments and formulation of inhaled therapies. Delegates will have the unique opportunity to hear presentations covering: developing a generic inhaled product, inhaled antibiotics and achieving an inhaled insulin product. Future directions in inhalation and respiratory drug delivery research as well as regulatory updates for inhaled therapies will also be addressed.
Day 1 – Development And Formulation Of Inhaled Therapies
- Combination product design
- Achieving an inhaled insulin product
- Developing a generic inhaled product
- Regulatory considerations for inhaled therapies
- Alternative therapeutic fields: inhaled antibiotics
- Future directions in inhalation and respiratory drug delivery research
On day two delegates will have the unique chance to join high-level discussions about inhalation devices and analytics. Our esteemed speakers will address topic areas covering novel technologies for pulmonary and nasal drug delivery and key advancements in analytical tools for inhaled therapies. Presentations will also extend to the challenges of developing inhalation devices as well as updates in improving patient adherence with product design.
Day 2 – Inhalation Devices And Analytics
- Novel technologies for pulmonary and nasal delivery
- The challenge of developing inhalation devices
- Dry Powder Inhalers (DPIs)
- Metered-dose inhalers (MDIs)
- Improving patient adherence with product design
- Establishing clear relationships between in vitro and in vivo data
- Analytical tools for inhaled medicines
Submit a Poster
For attendees interested in submitting a poster, there are opportunities now available. Your poster presentation will be located in the exhibition room for two days alongside other posters from senior scientists from the pharmaceutical industry and academic institutions.
How to submit your abstract
We will require:
- Poster title, Abstract (200 words or less)
- Principal author, Organisation
- Mailing address, Email, Telephone, Fax
- Additional authors
In order to secure your board space a fee of £250 plus VAT will be required. The poster should be presented as A0 (841mm x 1189mm) portrait size. To take advantage of this opportunity you need to be registered as a paid delegate over the 2 days. We have limited spaces available, so please register soon!